EXERT-BCH Exercise Regimen to Improve Muscle Mass After Treatment of Breast Cancer
Part of paid clinical trials in Pittsburgh, Pennsylvania.
- Sponsor
- Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
- Study ID
- NCT06115486
- Status
- Recruiting
Conditions
- Breast Cancer
- Breast Cancer Female
- Breast Carcinoma in Situ
Eligibility Criteria
- Sex
- FEMALE
- Age
- 20 Years - 89 Years
- Healthy Volunteers
- Not accepted
Interventions
- Control Arm ACSM Guidelines — OTHERThe control group will follow resistance training guidelines from the American College of Sports Medicine. Eight to ten multi-joint exercises will be performed to stress the major muscle groups.
- Experimental Arm 6-12-25 repetitions per set — OTHERThe exercise regimens will employ a mixture of compound exercises utilizing both open and closed kinetic chain movements (CKC), focusing on exercises with the goal of increasing skeletal muscle mass and body composition. The regimen will incorporate 6, then 12, then 25 repetitions in sequence per set per muscle group with minimal amounts of rest between.
Study Details
The purpose of this research study is to evaluate the outcomes of two standard of care group exercise regimens to increase muscle mass in women who have been treated with breast cancer.
Key Dates
- Start date
- Jan 9, 2024
- Status verified
- Feb 2026
- Primary completion
- Jan 31, 2027
- Completion
- Jan 31, 2027
Study Design
- Enrollment
- 30 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- OTHER
Arms
- Other: Control Arm / ACSM GuidelinesThe control group will follow resistance training guidelines from the American College of Sports Medicine (ACSM) with the goal of promoting hypertrophy
- Experimental: Experimental Arm / EOC GuidelinesThe experimental group will use a regimen that is often used by strength and conditioning coaches to maximize hypertrophy, and is part of the standard regimens at the Exercise Oncology Center (EOC)
Primary Outcome Measure
Determine changes in muscle and fat mass during and after each exercise regimen [ Time Frame: The exercise program will last for 8 weeks and continuously monitored by the PI and clinical team. ]
Central Contacts
- Clinical Trials Contact4123306151
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Allegheny General Hospital | Pittsburgh | Pennsylvania | 15212 | Clinical Trials Contact |
Find similar trials in Pittsburgh, PA
By condition
By specialty
By research site
Related Studies
- I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast CancerPHASE2 · Recruiting · QuantumLeap Healthcare Collaborative · Birmingham, Alabama
- Proteomics and Radiomics Research of Breast Cancer Markers in Tissue, Interstitial Fluid and SerumRecruiting · University of Pittsburgh · Pittsburgh, Pennsylvania
- Cardiotoxicity of Cancer Therapy (CCT)Enrolling By Invitation · Abramson Cancer Center at Penn Medicine · Philadelphia, Pennsylvania
- PENN-Surveillance Markers of Utility for Recurrence After (Neo)Adjuvant Therapy for Breast CancerRecruiting · Abramson Cancer Center at Penn Medicine · Philadelphia, Pennsylvania